Paul Hjemdahl
#123,188
Most Influential Person Now
Researcher
Paul Hjemdahl's AcademicInfluence.com Rankings
Paul Hjemdahlcomputer-science Degrees
Computer Science
#5048
World Rank
#5334
Historical Rank
Machine Learning
#1192
World Rank
#1212
Historical Rank
Artificial Intelligence
#1425
World Rank
#1454
Historical Rank
Database
#2214
World Rank
#2329
Historical Rank
Download Badge
Computer Science
Paul Hjemdahl's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Paul Hjemdahl Influential?
(Suggest an Edit or Addition)Paul Hjemdahl's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- [Guidelines on the management of stable angina pectoris: executive summary]. (2006) (705)
- Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method. (1979) (595)
- Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. (2006) (264)
- Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. (1983) (236)
- Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS) (1996) (228)
- Co-release of neuropeptide Y and catecholamines during physical exercise in man. (1985) (217)
- Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. (2008) (216)
- Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. (2001) (212)
- Platelet-Leukocyte Cross Talk in Whole Blood (2000) (212)
- The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. (2011) (212)
- The sympathetic response to euglycaemic hyperinsulinaemia (1992) (189)
- Differentiated sympathetic activation during mental stress evoked by the Stroop test. (1984) (188)
- Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. (1994) (187)
- Biochemical assessment of sympathetic activity and prejunctional modulation of noradrenaline release in humans. (1996) (182)
- Effects of serotonin on platelet activation in whole blood (1997) (170)
- Fetal and Maternal Plasma Catecholamine Levels at Elective Cesarean Section under General or Epidural Anesthesia Versus Vaginal Delivery (1982) (167)
- Evidence for prothrombotic effects of exercise and limited protection by aspirin. (1999) (164)
- [63] Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection (1987) (146)
- Plasma catecholamines--analytical challenges and physiological limitations. (1993) (143)
- Dose- and time-dependent antiplatelet effects of aspirin (2006) (140)
- Effects of stress and beta-blockade on platelet function. (1991) (135)
- Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension. (1983) (132)
- Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls. (1997) (129)
- Stress and the metabolic syndrome: an interesting but enigmatic association. (2002) (129)
- Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. (1989) (128)
- Importance of creatinine analyses of urine when screening for abused drugs. (1991) (127)
- Catecholamine measurements by high-performance liquid chromatography. (1984) (127)
- Muscle sympathetic activity and norepinephrine release during mental challenge in humans. (1989) (125)
- Cardiovascular and sympathoadrenal responses to mental stress: influence of beta-blockade. (1988) (123)
- Activation of haemostasis by exercise, mental stress and adrenaline: effects on platelet sensitivity to thrombin and thrombin generation. (1999) (120)
- Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol. Results from the Angina Prognosis study in Stockholm. (1997) (117)
- Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications (2011) (115)
- Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering. (1999) (114)
- Comparison of urinary and plasma catecholamine responses to mental stress. (1983) (114)
- Theophylline antagonizes cardiovascular responses to dipyridamole in man without affecting increases in plasma adenosine. (1984) (114)
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation (2016) (110)
- Platelets regulate CD4+ T-cell differentiation via multiple chemokines in humans (2011) (110)
- Comparison of calibrated dilute thrombin time and aPTT tests with LC-MS/MS for the therapeutic monitoring of patients treated with dabigatran etexilate (2013) (109)
- Renal neurohormonal and vascular responses to dynamic exercise in humans. (1991) (108)
- Does cardiovascular reactivity to mental stress have prognostic value in postinfarction patients? A pilot study. (1992) (106)
- Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation (2004) (106)
- Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma (2013) (104)
- Cardiovascular responses to circulating catecholamines in normal pregnancy and in pregnancy-induced hypertension. (1985) (103)
- Elevated serum intercellular adhesion molecule-1 and vascular adhesion molecule-1 among patients with stable angina pectoris who suffer cardiovascular death or non-fatal myocardial infarction. (1999) (100)
- Epinephrine-induced changes in muscle carbohydrate metabolism during exercise in male subjects. (1986) (96)
- Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release. (1989) (87)
- High glucose levels enhance platelet activation: involvement of multiple mechanisms (2006) (86)
- Cardiovascular and metabolic responses to low dose adrenaline infusion: an invasive study in humans. (1986) (84)
- Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion. (1983) (80)
- A sensitive flow cytometric assay for circulating platelet–leucocyte aggregates (1997) (79)
- Muscle sympathetic activity and venous plasma noradrenaline concentrations during static exercise in normotensive and hypertensive subjects. (1987) (78)
- Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. (1994) (77)
- Comparison of the lipolytic activity of circulating and locally released noradrenaline during acidosis. (1974) (73)
- Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ. (1984) (73)
- Comparison of subcutaneous injection and high-dose inhalation of epinephrine--implications for self-treatment to prevent anaphylaxis. (1986) (73)
- Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis (2003) (72)
- Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. (1998) (72)
- Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. (2006) (71)
- Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris (2002) (70)
- Inter-laboratory comparison of plasma catecholamine determinations using several different assays. (1984) (70)
- Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance. (1992) (69)
- Forecasting drug utilization and expenditure in a metropolitan health region (2010) (69)
- Sympatho‐adrenal and cardiovascular reactivity in pregnancy‐induced hypertension. I. Responses to isometric exercise and a cold pressor test (1985) (69)
- Quality of life on antihypertensive drug therapy: scientific end-point or marketing exercise? (1992) (68)
- Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection. (1987) (68)
- Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. (2003) (67)
- Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS) (2005) (67)
- Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid. (1998) (66)
- Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system. (2013) (66)
- Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris. (1995) (65)
- Platelet–lymphocyte conjugation differs between lymphocyte subpopulations (2006) (64)
- Enhanced leukocyte–platelet cross‐talk in Type 1 diabetes mellitus: relationship to microangiopathy (2004) (63)
- On the accurate determination of serotonin in human plasma. (1993) (62)
- Vascular and metabolic effects of circulating epinephrine and norepinephrine. Concentration-effect study in dogs. (1979) (61)
- Adipose tissue and skeletal muscle blood flow during mental stress. (1989) (61)
- Estimation of dabigatran plasma concentrations in the perioperative setting (2014) (60)
- Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle. (1984) (60)
- Renal venous outflow and urinary excretion of norepinephrine, epinephrine, and dopamine during graded renal nerve stimulation. (1983) (60)
- Platelet Activity, Coagulation, and Fibrinolysis During Exercise in Healthy Males: Effects of Thrombin Inhibition by Argatroban and Enoxaparin (2006) (59)
- Sympathoadrenal and cardiovascular responses to mental stress, isometric handgrip, and cold pressor test in asymptomatic young men with primary T wave abnormalities in the electrocardiogram. (1981) (58)
- Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins (2003) (57)
- Influence of Metoprolol Treatment on Sympatho-Adrenal Activation of Fibrinolysis (1990) (55)
- Influence of circulating NE and Epi on adipose tissue vascular resistance and lipolysis in humans. (1983) (54)
- Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. (2000) (53)
- Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study (2018) (53)
- Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension. (1994) (53)
- On the monitoring of dabigatran treatment in "real life" patients with atrial fibrillation. (2014) (52)
- Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. (2003) (52)
- A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing. (1988) (51)
- Marked increase of fibrin gel permeability with very low dose ASA treatment. (2005) (51)
- Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners (2001) (50)
- Physiological aspects on catecholamine sampling. (1987) (50)
- Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA2DS2VASc scores: experience from the Stockholm region (2014) (50)
- Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty (2006) (49)
- Influence of statin treatment on platelet inhibition by clopidogrel – a randomized comparison of rosuvastatin, atorvastatin and simvastatin co‐treatment (2009) (47)
- Diet induced changes in sympatho-adrenal activity during submaximal exercise in relation to substrate utilization in man. (1982) (47)
- Renal responses to mental stress and epinephrine in humans. (1989) (47)
- Plasma catecholamines following nursing procedures in a neonatal ward. (1986) (47)
- Platelet Activity In Vivo in Hyperlipoproteinemia – Importance of Combined Hyperlipidemia (1998) (46)
- Studies in vivo and in vitro of terbutaline-induced beta-adrenoceptor desensitization in healthy subjects. (1987) (46)
- Sympathoadrenal and cardiovascular reactivity in pregnancy-induced hypertension. II. Responses to tilting. (1985) (45)
- Cardiovascular and sympathoadrenal responses to mental stress: a study of sensory intake and rejection reactions. (1990) (45)
- Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. (1989) (45)
- Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls (1997) (45)
- Effects of prolonged adrenaline infusion and of mental stress on plasma minerals and parathyroid hormone. (1990) (44)
- Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. (1999) (43)
- Cyclic AMP-dependent and independent inhibition of lipolysis by adenosine and decreased pH. (1976) (43)
- Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity (2007) (43)
- Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus (2001) (43)
- Effects of policy interventions on the introduction of novel oral anticoagulants in Stockholm: an interrupted time series analysis (2017) (42)
- Fetal scalp catecholamines during labor. (1983) (42)
- Calcium antagonist treatment, sympathetic activity and platelet function. (1997) (41)
- Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. (1993) (41)
- Platelet aggregability in humans: contrasting in vivo and in vitro findings during sympatho‐adrenal activation and relationship to serum lipids (1990) (41)
- Altered cardiovascular responsiveness to adrenaline in endurance-trained subjects. (1986) (41)
- Effects of flumazenil in the treatment of benzodiazepine withdrawal – a double-blind pilot study (1997) (41)
- Stress‐induced changes in blood pressure and left ventricular function in mild hypertension (1991) (41)
- Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS). (2000) (41)
- Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment (1999) (41)
- Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction (2004) (41)
- Pre‐eclampsia: a state of sympathetic over‐activity (1998) (40)
- Is DDD Pacing Superior to VVI,R? A Study on Cardiac Sympathetic Nerve Activity and Myocardial Oxygen Consumption at Rest and During Exercise (1992) (40)
- Psychosocial variables in female vs male patients with stable angina pectoris and matched healthy controls. (1997) (40)
- Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. (1989) (40)
- Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade. (1991) (39)
- Sympatho-adrenal and cardiovascular response to mental stress and orthostatic provocation in latent hypertension. (1979) (39)
- Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle. (1988) (39)
- Effects of selective LDL‐apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia (1994) (39)
- Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. (1992) (39)
- Gemfibrozil Reduces Thrombin Generation in Patients with Combined Hyperlipidaemia, without Influencing Plasma Fibrinogen, Fibrin Gel Structure or Coagulation Factor VII (1996) (38)
- Effects of inhaled nitric oxide compared with aspirin on platelet function in vivo in healthy subjects. (1996) (37)
- Effect of clopidogrel treatment on stress-induced platelet activation and myocardial ischemia in aspirin-treated patients with stable coronary artery disease (2007) (37)
- Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients (1995) (37)
- Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non–Vitamin K Antagonist Oral Anticoagulants: The Stockholm Experience (2018) (36)
- Treatment of stable angina pectoris with calcium antagonists and beta-blockers. The APSIS study. Angina Prognosis Study in Stockholm. (1995) (36)
- The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS. (1997) (35)
- Renal responses to lower body negative pressure in humans. (1990) (35)
- [Guidelines on the management of stable angina pectoris; the experts of the European Society of Cardiology on the management of stable angina pectoris]. (2006) (35)
- Beta-adrenoceptors in human alveolar macrophages isolated by elutriation. (1990) (35)
- Biphasic pro‐thrombotic and inflammatory responses after coronary artery bypass surgery (2003) (34)
- Significance of Platelet β-Adrenoceptors for Platelet Responses In Vivo and In Vitro (1992) (34)
- Pace variation and control of work pace as related to cardiovascular, neuroendocrine, and subjective responses (1986) (33)
- Personal control over work pace--circulatory, neuroendocrine and subjective responses in borderline hypertension. (1986) (33)
- Cardiovascular and sympatho-adrenal responses to mental stress in primary hypertension. (1993) (33)
- Sympathoadrenal reactivity in exercise-induced asthma. (1982) (33)
- Sustained forearm vasodilation in humans during mental stress is not neurogenically mediated. (1996) (33)
- No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. (1997) (32)
- Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands. (1995) (32)
- Regional variation and adherence to guidelines for drug treatment of asthma (2010) (32)
- Blockade of endogenous nitric oxide production results in moderate hypertension, reducing sympathetic activity and shortening bleeding time in healthy volunteers (1997) (31)
- Prothrombotic responses to exercise are little influenced by clopidogrel treatment. (2004) (31)
- Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP. (1996) (31)
- Meal‐induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide (2006) (31)
- Plasma catecholamines as markers for sympatho-adrenal activity in human primary hypertension. (1988) (30)
- Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry. (1991) (30)
- Sympathoadrenal and cardiovascular reactivity in pregnancy-induced hypertension (1985) (30)
- [Guidelines on the management of stable angina pectoris. Executive summary]. (2006) (30)
- Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels. (1996) (30)
- On the accurate measurement of serotonin in whole blood. (1998) (30)
- Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions (2012) (30)
- Psychosocial and physiological factors in relation to blood pressure at rest--a study of Swedish men in their upper twenties. (1985) (29)
- Renal extraction of endogenous and radiolabelled catecholamines in the dog. (1986) (29)
- Beta-adrenergic receptor responsiveness to isoprenaline in humans: concentration-effect, as compared with dose-effect evaluation and influence of autonomic reflexes. (1989) (29)
- Influence of Angiotensin‐Converting Enzyme Inhibition on Sympathetic Neurotransmission: Possible Roles of Bradykinin and Prostaglandins (1992) (28)
- Insulin enhances platelet activation in vitro. (2001) (26)
- Neurohormonal activation in heart failure after acute myocardial infarction treated with beta‐receptor antagonists (2002) (26)
- Multi-Cellular Activation In Vivo by Endotoxin in Humans – Limited Protection by Adenosine Infusion (2000) (26)
- Effects of mental and physical stress on central haemodynamics and cardiac sympathetic nerve activity during QT interval-sensing rate-responsive and fixed rate ventricular inhibited pacing. (1990) (26)
- No evidence that the PLA1/PLA2 polymorphism of platelet glycoprotein IIIa is implicated in angiographically characterized coronary atherosclerosis and premature myocardial infarction (2003) (26)
- Does the Russell Viper Venom time test provide a rapid estimation of the intensity of oral anticoagulation? A cohort study. (2015) (26)
- Rebound phenomena following gradual withdrawal of chronic metoprolol treatment in patients with ischemic heart disease. (1984) (25)
- Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues. (1989) (25)
- Inhibition by acidosis of adenosine 3',5'-cyclic monophosphate accumulation and lipolysis in isolated rat fat cells. (1976) (25)
- Gemfibrozil enhances platelet activity in patients with combined hyperlipoproteinemia. (1995) (25)
- Effect of tilting on adipose tissue vascular resistance and sympathetic activity in humans. (1982) (25)
- Cardiovascular prognosis in relation to apolipoproteins and other lipid parameters in patients with stable angina pectoris treated with verapamil or metoprolol: results from the Angina Prognosis Study in Stockholm (APSIS). (1997) (25)
- Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. (1998) (25)
- On the mechanism by which antiadrenergic drugs increase survival of critical skin flaps. (1983) (25)
- Platelet hyperprocoagulant activity in Type 2 diabetes mellitus: attenuation by glycoprotein IIb/IIIa inhibition (2008) (24)
- Sex and Gender Differences in Thromboprophylactic Treatment of Patients With Atrial Fibrillation After the Introduction of Non-Vitamin K Oral Anticoagulants. (2017) (24)
- Adenosine Treatment Attenuates Cytokine Interleukin-6 Responses to Endotoxin Challenge in Healthy Volunteers (2003) (24)
- Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study in Stockholm [APSIS]). (1999) (24)
- Metabolic effects of blood flow restriction in adipose tissue. (1979) (23)
- Postprandial Platelet Activation Is Related to Postprandial Plasma Insulin Rather Than Glucose in Patients With Type 2 Diabetes (2012) (23)
- Influence of afferent renal nerve activity on contralateral renal overflow of noradrenaline and dopamine to plasma in the dog. (1986) (23)
- Acute effects of angiotensin II on fibrinolysis in healthy volunteers. (1999) (23)
- Nonadrenergic Sympathetic Vascular Control of the Human Forearm in Hypertension: Possible Involvement of Neuropeptide Y (1992) (22)
- Influence of beta-adrenergic receptor function during terbutaline treatment on allergen sensitivity and bronchodilator response to terbutaline in asthmatic subjects. (1992) (22)
- Long-term persistence and adherence with non-vitamin K oral anticoagulants in patients with atrial fibrillation and their associations with stroke risk (2020) (22)
- Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy. (1981) (22)
- No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance (2008) (22)
- A new assay for -thromboglobulin in urine (1991) (22)
- Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease. (2016) (22)
- Release of Catecholamines Is Increased but Does Not Contribute to the Impaired Insulin Secretion in the Perfused Pancreata of Diabetic Rats (1993) (21)
- Lipid‐lowering treatment and inflammatory mediators in diabetes and chronic kidney disease (2014) (21)
- From laboratory to clinical practice: Dabigatran effects on thrombin generation and coagulation in patient samples. (2015) (20)
- Thromboxane metabolite excretion during pregnancy--influence of preeclampsia and aspirin treatment. (2011) (20)
- Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional α‐ and β‐adrenoceptors in vivo (1988) (20)
- Prognosis of patients with stable angina pectoris on antianginal drug therapy. (1996) (20)
- Gender-related differences in response to placebo in benzodiazepine withdrawal: a single-blind pilot study (2000) (20)
- Renal and systemic plasma immunoreactive neuropeptide Y and calcitonin gene-related peptide responses to mental stress and adrenaline in humans. (1991) (20)
- Reflex activation of renal nerves in humans: differential effects on noradrenaline, dopamine and renin overflow to renal venous plasma. (1988) (19)
- Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction. (1990) (19)
- Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant. (1993) (19)
- Catecholamine measurements in urine by high-performance liquid chromatography with amperometric detection--comparison with an autoanalyser fluorescence method. (1989) (19)
- Cardiovascular responses to isometric handgrip exercise: an invasive study in pregnancy-induced hypertension. (1987) (19)
- Stimulation and inhibition of cyclic AMP formation in isolated rat fat cell by prostacyclin (PGI2). (1980) (19)
- β-Adrenoceptor Function in White Blood Cells from Newborn Infants: No Relation to Plasma Catecholamine Levels (1986) (19)
- Influence of acetylcholine, peptides, and other vasodilators on endogenous noradrenaline overflow and vasoconstriction in canine blood perfused gracilis muscle. (1985) (19)
- Ischaemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls. Gender differences and relationships to catecholamines. (1998) (19)
- A comparison of noradrenaline, HMPG and VMA in plasma as indicators of sympathetic nerve activity in man. (1982) (18)
- Attenuation of forearm vasodilator responses to mental stress by regional beta-blockade, but not by atropine. (1997) (18)
- Sympathoadrenal and Cardiovascular Responses to Mental Stress in Pregnancy-Induced Hypertension (1986) (18)
- Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men (2004) (18)
- Hemodynamic and sympathoadrenal responses to mental stress during nitric oxide synthesis inhibition. (2004) (18)
- Megakaryocytic cells synthesize and platelets secrete α5-laminins, and the endothelial laminin isoform laminin 10 (α5β1γ1) strongly promotes adhesion but not activation of platelets (2005) (18)
- Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs (2017) (18)
- Cardiovascular System and Stress (2007) (18)
- The effect of dipyridamole on plasma adenosine levels and skin micro-circulation in man. (1984) (17)
- Effects of insulin on platelet and leukocyte activity in whole blood. (2002) (17)
- Altered cardiovascular responsiveness to adrenoceptor agonists in endurance-trained men. (1991) (16)
- Reduced ß2-Adrenoceptor Responsiveness in Exercise-induced Asthma (1985) (16)
- Acute effects of cigarette smoking on platelet function and plasma catecholamines in hypertensive and normotensive men. (1998) (16)
- Megakaryocytic cells synthesize and platelets secrete alpha5-laminins, and the endothelial laminin isoform laminin 10 (alpha5beta1gamma1) strongly promotes adhesion but not activation of platelets. (2006) (16)
- Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction? (2004) (15)
- Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers. (1999) (15)
- Bronchodilatation and inhibition of allergen-induced bronchoconstriction by circulating epinephrine in asthmatic subjects. (1985) (15)
- Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care (2011) (15)
- Prejunctional α‐Adrenoceptor-Mediated Inhibition of Norepinephrine Release in Blood‐Perfused Skeletal Muscle In Situ (1987) (15)
- Beta 2-agonist treatment reduces beta 2-sensitivity in alveolar macrophages despite corticosteroid treatment. (1996) (15)
- Cyclic AMP and metabolic substrates in hemorrhagic shock of the rat. (1977) (15)
- Effects of Prazosin on Hemodynamics and Sympatho‐Adrenal Activity in Hypertensive Patients (1983) (15)
- Long‐term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction (2009) (15)
- Inhibition of the renin–angiotensin system does not reduce platelet activity at rest or during stress in hypertension (2013) (14)
- Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide. (1987) (14)
- Facilitation of nerve stimulation evoked noradrenaline overflow by isoprenaline but not by circulating adrenaline in the dog in vivo. (1987) (14)
- Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system (2013) (14)
- Contrasting Cardiovascular Responses from Intrathecal Administration of Epinephrine and Norepinephrine in Conscious Rats: Role of α1 and α2-Adrenoceptors (1992) (13)
- Insulin, but not proinsulin C-peptide, enhances platelet fibrinogen binding in vitro in Type 1 diabetes mellitus patients and healthy subjects. (2002) (13)
- Vascular and metabolic responses to adrenergic stimulation in isolated canine subcutaneous adipose tissue at normal and reduced temperature. (1978) (13)
- Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial. (2012) (13)
- D‐Myo‐Inositol‐1,2,6‐Triphosphate (PP56) Antagonizes Nonadrenergic Sympathetic Vasoconstriction: Possible Involvement of Neuropeptide Y (1993) (13)
- Aspects of prostaglandin action on autonomic neuroeffector transmission. (1980) (12)
- Effects of treatment with oral isosorbide dinitrate on platelet function in vivo; a double-blind placebo-controlled study in patients with stable angina pectoris. (1994) (12)
- Reduced β2-Adrenoceptor Sensitivity in Normal Pregnancy but Not in Pregnancy-Induced Hypertension (1988) (12)
- Uptake and release of adenosine in isolated rat fat cells. (1979) (12)
- Lipid levels achieved after a first myocardial infarction and the prediction of recurrent atherosclerotic cardiovascular disease. (2019) (12)
- Association of preceding antithrombotic therapy in atrial fibrillation patients with ischaemic stroke, intracranial haemorrhage, or gastrointestinal bleed and mortality (2019) (12)
- Prejunctional β2-Adrenoceptor -Mediated Enhancement of Noradrenaline Release in Skeletal Muscle Vasculature In Situ (1987) (12)
- Sympathoadrenal responses to bronchoconstriction in asthma: an invasive and kinetic study of plasma catecholamines. (1995) (12)
- Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro. (1992) (12)
- Influence of adipose tissue blood flow on the lipolytic response to circulating noradrenaline at normal and reduced pH. (1976) (12)
- Degeneration release of noradrenaline in skin flaps in rats. (1981) (12)
- Pre- and postjunctional alpha-adrenoceptor-mediated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine skeletal muscle in situ. (1987) (12)
- Smoking, nicotine and thrombotic risk--a role for platelet dependent thrombin generation? (2001) (12)
- Autologous low density lipoprotein enhances platelet aggregation in whole blood, as measured by in vitro filtragometry. (1993) (12)
- Platelet function one and three months after coronary bypass surgery in relation to once or twice daily dosing of acetylsalicylic acid. (2017) (11)
- Monitoring of coagulation factor therapy in patients with von Willebrand disease type 3 using a microchip flow chamber system (2016) (11)
- Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries (2021) (11)
- Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris (2008) (11)
- Psychosocial variables in relation to various risk factors in patients with stable angina pectoris (2000) (11)
- Flow dependence of forearm noradrenaline overflow, as assessed during mental stress and sodium nitroprusside infusion. (1999) (11)
- Analysis of phenylephrine in plasma: Initial data about the concentration-effect relationship (2004) (11)
- Lessons from 20 years with COX‐2 inhibitors: Importance of dose–response considerations and fair play in comparative trials (2022) (11)
- Effects of Stress and 3-Blockade on Platelet Function (2005) (11)
- Age and gender differences in left ventricular function among patients with stable angina and a matched control group. A report from the Angina Prognosis Study in Stockholm. (1996) (11)
- Mental stress and adrenaline increase plasma growth factor activity in humans. (1989) (11)
- Should we monitor platelet function during antiplatelet therapy? (2008) (11)
- Cardiovascular reactivity to mental stress during gradual withdrawal of chronic postinfarction treatment with metoprolol. (1986) (10)
- Elevations of neuropeptide Y‐like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig (1987) (10)
- Influence of acidosis on noradrenaline-induced vasoconstriction in adipose tissue and skeletal muscle. (1976) (10)
- Gemfibrozil-induced decrease in serum ubiquinone and alpha- and gamma-tocopherol levels in men with combined hyperlipidaemia. (1998) (10)
- Determination of perhexiline and hydroxyperhexiline in plasma by liquid chromatography-mass spectrometry. (2004) (10)
- The impact of diabetes or elevated fasting blood glucose on cardiovascular prognosis in patients with stable angina pectoris (2005) (10)
- Renal overflow of noradrenaline and dopamine to plasma during hindquarter compression and thoracic inferior vena cava obstruction in the dog. (1986) (10)
- Haemostatic Effects of Stress (2011) (10)
- Antilipolytic effect of adenosine in isolated perifused fat cells. (1978) (10)
- Improvement of the isoprenaline infusion test by plasma concentration measurements. (1986) (10)
- Increased release of norepinephrine and dopamine from canine kidney during bilateral carotid occlusion. (1987) (10)
- Unchanged peripheral sympathetic activity following withdrawal of chronic metoprolol treatment. A study of noradrenaline concentrations and kinetics in plasma. (1984) (10)
- Effects of an oral dose of isosorbide dinitrate on platelet function and fibrinolysis in healthy volunteers. (1993) (9)
- Effects of adrenaline on ventricular function and coronary haemodynamics in relation to catecholamine handling in transplanted human hearts. (1993) (9)
- Introduction to Cardiovascular Disease, Stress and Adaptation (2011) (9)
- Acute bronchoconstriction is not a stimulus for sympatho-adrenal activation in asthmatic or healthy subjects. (1990) (9)
- Effects of sympatho-adrenal activation on the finger microcirculation in mild hypertension. (1992) (9)
- Risk prediction in stable angina pectoris (2013) (9)
- Neither endogenous nor inhaled nitric oxide influences the function of circulating platelets in healthy volunteers (1999) (9)
- Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes. (2001) (9)
- Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo (1988) (9)
- Development of myocardial beta-adrenergic receptor density and adenylate cyclase activity after human heart transplantation. (1992) (9)
- Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery (2018) (8)
- Rebound phenomena following withdrawal of long-term beta-adrenoceptor blockade. (1982) (8)
- Reduction of serum parathyroid hormone levels during sympathetic stimulation in man (1987) (8)
- [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment]. (2008) (8)
- Studies on the antilipolytic effect of acidosis. (1976) (8)
- Concomitant Anticoagulant and Antidepressant Therapy in Atrial Fibrillation Patients and Risk of Stroke and Bleeding (2020) (8)
- Aspirin resistance testing not ready for “prime time” (2009) (8)
- Platelet reactivity, exercise, and stable coronary artery disease. (1995) (8)
- [SBU should investigate what is an evidence-based and cost-effective use of statins]. (2009) (8)
- Direct antilipolytic effect of acidosis in isolated rat adipocytes. (1977) (8)
- Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo. (1994) (7)
- Differential index, a novel graphical method for measurements of heart rate variability. (2005) (7)
- Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet (2020) (7)
- Angiotensin II overflow from canine skeletal muscle in vivo: importance of plasma angiotensin I. (1994) (7)
- Sympathoadrenal and Cardiovascular Reactivity in Pregnancy-Induced Hypertension. II. Responses to Tilting (1986) (7)
- Sympatho-adrenal mechanisms and the antihypertensive response to thiazide diuretics. (2009) (7)
- Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus (2019) (7)
- Endogenous adenosine inhibits lipolysis induced by nerve stimulation without inhibiting noradrenaline release in canine subcutaneous adipose tissue in vivo (1981) (7)
- Rebound phenomena following withdrawal of long–term β–adrenoceptor blockade (2009) (7)
- Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors of Major Adverse Cardiovascular Outcomes in Patients With Coronary Heart Disease (2022) (6)
- Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo (1990) (6)
- Inhibition of the lipolytic response to nerve stimulation during acidosis. (1976) (6)
- Left ventricular dynamics and plasma catecholamines during isometric exercise in patients following cardiac transplantation. (1991) (6)
- Influence of angiotensin II, α- and β-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo (1992) (6)
- Increased sympathetic activity and blood pressure in young asymptomatic men with 'organic' T-wave aberrations in the electrocardiogram. (1980) (6)
- Meal-induced platelet activation in diabetes mellitus type 1 or type 2 is related to postprandial insulin rather than glucose levels. (2016) (6)
- Adhesion molecules and leucocyte counts are related to the degree of atherosclerosis in the carotid and femoral artery assessed by ultrasonography (2000) (6)
- Adrenaline, cyclic AMP and potassium during general anaesthesia with and without epidural analgesia. (1995) (6)
- Influence of circulating alpha adrenoceptor agonists on lung function in patients with exercise induced asthma and healthy subjects. (1986) (6)
- Endothelial COX-2 inhibition: possible relevance for hypertension and cardiovascular risk? (2003) (6)
- Exercise-induced platelet and leucocyte activation is not enhanced in well-controlled Type 1 diabetes, despite increased activity at rest (2004) (6)
- [Still questions around the slimming agent rimobant. Not approved in USA because of the risk of mental adverse effects]. (2007) (5)
- Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional alpha- and beta-adrenoceptors in vivo. (1988) (5)
- Electrocardiographic and vectorcardiographic findings in asymptomatic young men with primary T-wave aberrations in the electrocardiogram. Relationship to sympatho-adrenal activity at rest and during different stress tests. (1982) (5)
- Evidence against a functional role for dopamine-4-sulphate in the kidney. (1985) (5)
- Prognostic implications of renal dysfunction in patients with stable angina pectoris (2006) (5)
- Changes in cardiac metabolism, perfusion, ECG and plasma catecholamines during increased intracranial pressure in the pig (1987) (5)
- Reactivity to mental stress and cold provocation during long-term treatment with metoprolol, propranolol or hydrochlorothiazide. (1986) (5)
- No influence of circulating noradrenaline on bronchial reactivity to histamine in asthmatic patients. (1986) (5)
- Adrenaline responsiveness in mild hypertension: no evidence for altered beta-adrenoceptor sensitivity. (1998) (5)
- Metoprolol does not reduce platelet aggregability during sympatho-adrenal stimulation (2004) (5)
- [Fully possible to reduce the costs of hypertension treatment]. (2009) (4)
- Differences between the effects of metoprolol and prazosin on the forearm vasculature in primary hypertension (1997) (4)
- Prevention of cardiac events in patients with angina pectoris: Results of the APSIS study (1995) (4)
- Comparison between isoprenaline infusions and bolus injections to assess beta-adrenoceptor function in man, with special reference to cardiac contractility and the influence of autonomic reflexes. (1991) (4)
- Modification of commercial assay kits is justified. (1993) (4)
- Pharmac . ( 1989 ) , 28 , 83-94 3-adrenergic receptor responsiveness to isoprenaline in humans : concentration-effect , as compared with dose-effect evaluation and influence of autonomic reflexes (4)
- Lipid-lowering treatment intensity, persistence, adherence and goal attainment in patients with coronary heart disease. (2022) (4)
- Plasma noradrenaline and dopamine in renin-mediated hypertension. (1990) (4)
- Is there a causal relationship of anxiety, stress or cardiovascular reactivity to hypertension? (1991) (4)
- Using relation between urinary cannabinoid and creatinine excretions to improve monitoring of abuser adherence to abstinence. (1994) (4)
- [Thrombocyte activation. A link between stress and myocardial infarction?]. (1995) (3)
- Adrenaline responsiveness in borderline hypertension. (1986) (3)
- Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds (2021) (3)
- Release of Dopamine from the Kidney in vivo (1988) (3)
- Abstract 15018: Better Platelet Inhibition in Whole Blood is Achieved by Twice Daily Dosing of Aspirin in Patients With Type 2 Diabetes Mellitus. (2010) (3)
- beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide. (2001) (3)
- Bronchodilator treatment in asthma: continuous or on demand? (1992) (3)
- Comparison of the effects of different arachidonic acid metabolites on cyclic nucleotide accumulation in human peripheral lymphocytes. (2009) (3)
- Nerve stimulation augments angiotensin II overflow from canine gracilis muscle in vivo. (1991) (3)
- Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy. (1982) (3)
- Comprar Stress and Cardiovascular Disease | Steptoe, Andrew | 9781848824188 | Springer (2011) (3)
- Ethical Aspects of Measuring Adherence to Antihypertensive Treatment (2018) (3)
- Labetalol, a combined α– and β–blocker, in hypertension of pregnancy (2009) (3)
- Sympatho-adrenal regulation of adipose tissue blood flow in dog and man. (1983) (3)
- [Can we afford good cholesterol lowering therapy? Budgeting of statin costs versus medical needs in the county of Stockholm]. (2001) (2)
- No effect of oral hormone replacement therapy on platelet function in postmenopausal women with coronary artery disease (2006) (2)
- [Randomization and ethics. Patient participation is a serious demand in medical research]. (1992) (2)
- The effects of adenosine as adjuvant therapy in acute myocardial infarction on cardiovascular events. Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study (2001) (2)
- Reduced beta 2-adrenoceptor sensitivity in normal pregnancy but not in pregnancy-induced hypertension. (1988) (2)
- Mechanisms of exercise‐induced ST‐segment depression in patients without typical angina pectoris (2007) (2)
- Oral anticoagulants in patients with atrial fibrillation at low stroke risk: a multicentre observational study (2022) (2)
- 175 MONITORING OF METHADONE DOSE INTAKE: IMPORTANCE OF URINARY pH (1997) (2)
- Cardiovascular and Autonomic Responses to Stress (2011) (2)
- [New drug in atrial fibrillation--how does it function in regular health care?]. (2009) (2)
- Reduced beta 2-adrenoceptor responsiveness in exercise-induced asthma. (1985) (2)
- Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity. (2013) (2)
- Effects of flumazenil in the treatment of withdrawal : a double-blind pilot study (1997) (2)
- Possible beneficial effects of adenosine as adjubant therapy to thrombolytic treatment in patients with an acute anterior myocardial infarction and depressed left ventricular function (2003) (2)
- Heart rate variability in patients with angina pectoris (1994) (2)
- Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants. (2022) (2)
- [Lower and lower cholesterol targets increase adverse effects]. (2009) (1)
- Poor performance with a platelet counting technique to monitor clopidogrel inhibitory effects in the point-of-care setting. (2010) (1)
- 873 – TISSUE DIFFERENCES IN THE RELATIVE POTENCY OF PGI2 AND PGE:s: STUDIES ON HUMAN LYMPHOCYTES AND RAT ADIPOCYTES (1978) (1)
- Contrasting cardiovascular responses from intrathecal administration of epinephrine and norepinephrine in conscious rats: role of alpha 1- and alpha 2-adrenoceptors. (1992) (1)
- Sympatho-adrenal activity is assessed in patients with asthma by measurements of catecholamines and neuropeptide Y-like immunoreactivity (NPY-LI) in venous plasma. (1989) (1)
- Letter by Hjemdahl et al regarding article, "Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial". (2013) (1)
- [Improved stroke prevention in atrial fibrillation: the Stockholm experience of the introduction of NOACs]. (2018) (1)
- [Anti-obesity agents do not seem to have any beneficial effects. Health centers prescribe preparations haphazardly, according to a medical records study]. (2010) (1)
- Renal and systemic sympathetic counterregulation in response to vasodilators in renovascular hypertension. (1993) (1)
- [Autonomic nervous system--physiology and diagnosis]. (1983) (1)
- Sympathetic Nerve Activity during VVI and DDD Pacing (1989) (1)
- A new assay for beta-thromboglobulin in urine. (1991) (1)
- Intensity of lipid-lowering therapy, adherence and LDL-cholesterol goal attainment in patients with coronary heart disease (2022) (1)
- 115 Adrenaline‐induced increases in plasma noradrenaline in man are due to an increased nerve activity rather than to prejunctional modulation of transmitter release (1988) (1)
- Effects of Adrenaline and Mental Stress on Serum Digoxin Concentration (1991) (1)
- Dyspnea and antiplatelet drugs: Little cause for concern with clopidogrel (2008) (1)
- Results of in vitro whole blood coagulation assays using ROTEM and the flow-chamber T-TAS system are affected by hematocrit. (2020) (1)
- Abstract 13898: Atrial Fibrillation And Persistence With Anticoagulant Treatment (2015) (1)
- 1458Improved stroke prevention in atrial fibrillation after the introduction of NOACs; the Stockholm experience (2018) (1)
- Dilute Russell Viper Venom Time: A Useful Assay for the Monitoring of Direct Oral Anticoagulants in Patients? (2013) (1)
- Contrast medium attenuates platelet activation and platelet-leukocyte cross–talk (2005) (1)
- [Strong lobbying for direct -to-consumer advertising of prescription drugs. Beneficial for the patient or for the increase of sales?]. (2002) (0)
- A NEW ASSAY FOR BTHROMBGGLOBULIN IN URINE (1991) (0)
- [Sandomigrin Pizotifen Sandoz]. (1975) (0)
- Table 1. Basal Serum, Urine,and SalivaryCortisolConcentrations(nmol/L) In the GroupsStudiedand after Dexamethasone(DXM)SuppressionTests In Patientswith CushingSyndrome (1993) (0)
- [Visions are good but the guidelines require evidence]. (2011) (0)
- [Paradigm shift with the new American guidelines for lipid-lowering therapy]. (2014) (0)
- [Lioresal (Baclofen, Ciba)]. (1974) (0)
- 3053High mortality in atrial fibrillation patients suffering ischemic stroke, intracranial hemorrhage or a gastrointestinal bleed and associations with the preceding antithrombotic treatment (2019) (0)
- A.365 infusion of L-NMMA reduces human nasal nitric oxide levels (1996) (0)
- Support for a physiological significance of the platelet β-adrenoceptor (1990) (0)
- P171Low density lipoprotein cholesterol levels at first follow-up after acute myocardial infarction predicts recurrent atherosclerotic cardiovascular disease events poorly (2017) (0)
- Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation (2015) (0)
- Increased thromboxane production in preeclampsia, influence of aspirin treatment (2009) (0)
- [Swedish medical research does not need more control]. (2014) (0)
- Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs (2017) (0)
- [Accreditation should be discussed! Need for substance abuse testing at the workplace should be increased]. (1998) (0)
- Response to: Kumar N, Ahmed M. Letter to the editor in response to Komen et al. 2021 (2021) (0)
- Is left ventricular diastolic function an independent determinant of prognosis in patients with an acute myocardial infarction treated with thrombolysis (2002) (0)
- [Bleeding and surgery in the treatment with new oral anticoagulants. The management can be complicated by the lack of specific antidotes]. (2014) (0)
- Gemfibrozil enhances platelet activity in vivo in patients with combined hyperlipoproteinemia: a double-blind, placebo-controlled study (1994) (0)
- [More with atrial fibrillation, anticoagulants since the coming of NOAK ]. (2015) (0)
- Gender related differences in benzodiazepine withdrawal : a single-blind pilot study (2001) (0)
- [More evidence against COX-2 inhibitors. The risk of severe cardiovascular complications more and more obvious]. (2007) (0)
- [Use and abuse of substance abuse analyses in urine]. (1991) (0)
- P3582Increased thromboprophylactic treatment of patients with atrial fibrillation after the introduction of NOACs - an analysis of sex and gender differences (2017) (0)
- Influence of angiotensin II, alpha- and beta-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo. (1992) (0)
- Abstract P430: Role of Cystatin C-based Estimated Glomerular Filtration Rate for Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation (2023) (0)
- [Hypertension in young people in relation to psychosocial factors]. (1985) (0)
- MO514: Cardiorenal Outcomes Associated With Oral Anticoagulant Use in Patients With Atrial Fibrillation (2022) (0)
- Association of combined intensity and adherence to statin/ezetimibe therapy with major adverse cardiovascular outcomes in patients with coronary heart disease (2022) (0)
- Effect of renal impairment on atherosclerosis: only partially mediated by homocysteine (2016) (0)
- 990-53 Effects on Cardiovascular End Points and Psychological Variables of Metoprolol and Verapamil in Patients with Stable Angina Pectoris — The Angina Prognosis Study in Stockholm (APSIS) (1995) (0)
- 14 EVALUATION OF IMMUNOLOGICAL SCREENING ASSAYS FOR BENZODIAZEPINES IN URINE USING CLINICAL SAMPLES (1995) (0)
- [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!]. (2006) (0)
- A.274 Infusion during 60 min of L-NMMA to healthy volunteers (1996) (0)
- β-Thromboglobulin in Urine and Plasma (1998) (0)
- Neurohormonal activation in heat failure Persson et al-2002-European Journal of Heart Failure (2015) (0)
- 1468 – INHIBITION BY ACIDOSIS OF CYCLIC AMP ACCUMULATION IN ISOLATED RAT ADIPOCYTES (1977) (0)
- [Handling of platelet inhibitors in connection with surgery. Platelet function tests can contribute to wise decisions]. (2013) (0)
- Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma (2013) (0)
- 2.P.344 Platelet function in hypercholesterolemia - importance of combine hyperlipidemia (1997) (0)
- No effects of Adenosine as adjuvant therapy in thrombolysed acute myocardial infarction (2000) (0)
- Risks for stroke and bleeding with warfarin or aspirin treatment in patients with atrial fibrillation at different CHA2DS2VASc scores: experience from the Stockholm region (2014) (0)
- Beta-thromboglobulin in urine and plasma: influence of coronary risk factors. (1998) (0)
- Medical decision making / Psycho-social and behavioural risk factors 233 MEDICAL DECISION MAKING PSYCHO-SOCIAL AND BEHAVIOURAL RISK FACTORS P1356 Patient care enhancement with continuous quality Improvement techniques (2005) (0)
- Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply. (2013) (0)
- [Committees dealing with research ethics are being educated in biotechnology, child research, priority decisions]. (1991) (0)
- 2.P.352 Low or medium dose acetylsalicylic acid increases fibrin gel porosity is healthy adults (1997) (0)
- [Say no to the extremes in the debate on lipid reduction]. (2011) (0)
- Primary prevention in patients with coronary heart disease: The APSIS study (1995) (0)
- C0144: Is there a Role for Standard Thrombin Time (TT) Measurements for the Monitoring of Low Levels of Dabigatran? (2014) (0)
- P4745Concomitant oral anticoagulant and antidepressant therapy in patients with atrial fibrillation and risk of stroke and bleeding: a population based cohort study (2019) (0)
- primary hypertension Acute and chronic calcium antagonist treatment elevates sympathetic activity in (2011) (0)
- [Unclear recommendations from the National Board of Drug and Narcotic Control on the treatment of asthma]. (1991) (0)
- [Scientific fraud--ethical considerations. A medical ad hoc group should make a prompt investigation]. (1994) (0)
- [LFN's evaluation of Inspra illustrates the need of drug committees!]. (2005) (0)
- Influence of β1-blockade on alterations In human platelet aggregability by mental stress and adrenaline infusions (1990) (0)
- Methods to monitor dabigatran: first clinical experience in patients with atrial fibrillation (2013) (0)
- Is Dilute Russell’s Viper Venom Time a Useful Assay To Monitor Patients Treated By Rivaroxaban Or Dabigatran Etexilate? (2013) (0)
- [Reply from the SBU about salt and high blood pressure: More controlled long-term trials are required]. (2004) (0)
- Acute bronchoconstriction is not a stimulus for (2012) (0)
- [Dynamic regulation of adrenergic receptors--stress, disease, drugs can affect their function]. (1986) (0)
- Adrenaline Infusion in heart transplanted patients: effects on hemodynamics and myocardial metabolism of catecholamines (1990) (0)
- VI-72 Fibrinogen and Plasminogen Activator Inhibitor-1 Levels in Hypertension and Coronary Heart Disease Potential Effects of P-Blockade (2005) (0)
- Whole blood flow cytometric analysis of plateletleucocyte aggregates: methodological and mechanistic factors (1997) (0)
- Can the metabolic syndrome be explained by a unifying concept? (2015) (0)
- Influence of circulating ac adrenoceptor agonists on lung function in patients with exercise induced asthma and healthy subjects (2004) (0)
- [Quality of life during treatment of hypertension. What is belief and what is knowledge?]. (1993) (0)
- Insulin enhances platelet activation and aggregation in vitro (2000) (0)
- CIRCULATORY AND METABOLIC EFFECTS OF A COMBINED a-AND f3-ADRENOCEPTOR BLOCKER (LABETALOL) IN HYPERTENSION OF PREGNANCY (2006) (0)
- [New guidelines for the treatment of hypertension--what has really happened since the last time?]. (1990) (0)
- 3-adrenergic receptor responsiveness toisoprenaline in humans: concentration-effect, ascompared withdose-effect evaluation andinfluence ofautonomic reflexes (1989) (0)
- [Rational introduction to new drugs requires both a health care and a community perspective]. (2009) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Paul Hjemdahl?
Paul Hjemdahl is affiliated with the following schools:
